<DOC>
	<DOCNO>NCT00002311</DOCNO>
	<brief_summary>To study safety efficacy four different dos Wobenzym ( enzyme combination consist pancreatin , papain , bromelain , trypsin , lipase , amylase , chymotrypsin , rutin ) patient HIV infection whose CD4 count 250 400 cells/mm3 . To evaluate effect Wobenzym certain surrogate marker associate progression HIV disease .</brief_summary>
	<brief_title>The Safety Four Different Dose Levels Wobenzym HIV-Positive Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Wobenzym</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV seropositivity CD4 count 250 400 cells/mm3 . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Known hypersensitivity hydrolytic enzyme Wobenzym . Known sensitivity lactose . Presumption patient comply dose schedule followup appointment . Concurrent Medication : Excluded : Concurrent use immunosuppressive therapy steroid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1993</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Wobenzym</keyword>
	<keyword>Hydrolases</keyword>
</DOC>